Preventicus Appoints Ljubisav Matejevic as Chief Sales and Marketing Officer and Member of the Executive Board

Preventicus Preventicus is proud to announce that the company continues to grow by bringing its unique, comprehensive care management programs for prevention of strokes and cardiovascular events to new international markets. By appointing Ljubisav Matejevic as Chief Sales and Marketing Officer and Member of the Executive Board, Preventicus strengthens its management team as well as its international focus. Ljubisav Matejevic will be responsible for the International Sales Team Leadership, Business Development, Marketing, and Strategy as well as further developing Preventicus Global Ecosystem of governmental, academic, and industry healthcare leaders. Moreover, he will act as CEO of Preventicus Managed Care (Division of Preventicus GmbH).

Ljubisav Matejevic comes to Preventicus with over 25 years of international market and business development experience. He combines profound expertise in scaling business with excellent thought leadership. Previously, Ljubisav Matejevic was the Vice President Ascom Central and Eastern Europe (CEE), led their Global Strategic Alliances team, and scaled the Global Healthcare Ecosystem for the Swiss company. Prior to his roles at Ascom, Ljubisav Matejevic represented as Global Market Development and Strategy Executive IBM’s Global Healthcare and Life Sciences Business (HCLS) and had held leadership positions in various other Healthcare IT companies.

Dr. Thomas Huebner, CEO of Preventicus, states: "We are very excited to welcome Ljubisav Matejevic to the Preventicus team. Our vision to contribute to 'healthy aging' by offering integrated care programs and innovative technologies for screening, diagnosis, and management of cardiovascular diseases, such as Atrial Fibrillation, meets with increased interest from all over the world. Ljubisav's experience in developing international markets and strong partnerships will strongly complement Preventicus strategic direction. He will focus on the expansion of our international markets as well as on establishing Preventicus as the trusted advisor and solution provider in the context of stroke prevention."

Ljubisav Matejevic emphasizes: "According to the American Heart Association, stroke is one of the leading causes of disability and death worldwide - and one of the major economic burdens for healthcare systems across the globe. On the other hand, clinical studies have proven that nine out of ten strokes are preventable. The main risk factors include undetected cardiac rhythm disorders, primarily atrial fibrillation. I am enthusiastic to join Preventicus and to be in a position to significantly contribute to not only preventing cerebrovascular accidents worldwide with our comprehensive managed care programs, but also providing a solution that enables healthcare systems to significantly reduce their cost burden linked to stroke, chronic, and acute cardiovascular events."

About Preventicus

Preventicus offers full service integrated care programs for screening, diagnosis, and management of cardiovascular diseases, such as Atrial Fibrillation. Preventicus' unique managed care program has shown to identify and diagnose patients with previously unknown Atrial Fibrillation in a cost-effective manner that allows to reduce the overall costs linked to stroke. Distinctive features of Preventicus are superior biosignal-analytic algorithms - certified as a CE class IIa medical product, with worldwide unrivalled clinical evidence - enabling risk screening by smartphone (via App "Preventicus Heartbeats") or wearables ("Preventicus Nightwatch"). These state-of-the-art medical technologies are embedded in comprehensive managed care programs, including telemedical services ("Telecare") as well as an intelligent IT ecosystem ("Caresafe" and "Carenet") for health insurers and providers. Outstanding features of the Preventicus care management programs are the completely digital structures and the pseudonymized concept with a maximum of data protection and data economy.

Most Popular Now

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

DigiConnect: e-healthcare - 24/7 Health …

Given the current outbreak of COVID-19, healthcare providers in the Middle East along with the rest of the world are currently putting relentless efforts to provide an innovative offering that...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...